May 31, 2011 PXE News

May 31, 2011
Lucentis and Avastin Equally Effective for AMD
On April 28, 2011, the New England Journal of Medicine published online the highly anticipated one-year results from a two-year clinical trial showing that Lucentis® and Avastin® were equally effective in preserving vision in people with wet age-related macular degeneration (AMD). The study also revealed that safety of the two treatments was similar, and that "as needed" dosing is a viable treatment option for either drug.

If this information was helpful to you, please consider making a quick donation today because every penny counts. 100% of donations go to support and research.